Cybrdi, Inc. Stock

Equities

CYDI

US23254K1007

Biotechnology & Medical Research

Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Cybrdi, Inc. -.--% -50.91%
Sales 2012 783K Sales 2013 574K Capitalization 1.56M
Net income 2012 - Net income 2013 - EV / Sales 2012 3.25 x
Net Debt 2012 1.58M Net Debt 2013 3.99M EV / Sales 2013 9.67 x
P/E ratio 2012
-1.82 x
P/E ratio 2013
-2.85 x
Employees -
Yield 2012 *
-
Yield 2013
-
Free-Float 29.19%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 61 02-12-31
Chief Operating Officer - 11-08-18
Members of the board TitleAgeSince
Chief Executive Officer 61 02-12-31
Chief Operating Officer - 11-08-18
More insiders
Cybrdi Inc is a united states-based company, which operates as a holding company. The Company's subsidiaries include Chaoying Biotech which is engaged in biotechnology manufacturing, and research and development company. Through Chaoying Biotech, Cybrdi controls SD Chaoying, a Cultural and Entertainment company. Its key product is tissue chips, intended to provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. The Company’s Tissue Microarrays (TMAs) segment offers a variety of tissue array products and services on the commercial market. The Technical Services segment provides in-house technical services platform to perform customized research according to customer specifications. The Culture, Entertainment, and Real Estate Business segment is developing a Culture and Entertainment Square in Changle City of Shandong Province.
More about the company